<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00382903835317</udiDi>
    <basicUdiDi>038290OZPDTPTEPP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383531</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:44:32.541Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836505</udiDi>
    <basicUdiDi>038290BTGFDFRO57</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383650</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:44:23.901Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835126</udiDi>
    <basicUdiDi>038290MCBLCMJW3C</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383512</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:44:23.884Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836475</udiDi>
    <basicUdiDi>038290BTGFDFRO57</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383647</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:41:56.179Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836468</udiDi>
    <basicUdiDi>038290BTGFDFRO57</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383646</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:41:56.150Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835508</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383550</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:51:55.123Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835706</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383570</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:51:54.822Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835720</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383572</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:24.058Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835522</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383552</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:24.012Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835799</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PERIPHERAL I.V. CATHETERS, WITH INTEGRATED EXTENSIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383579</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:23.955Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835577</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383557</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:09.554Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835607</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383560</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:09.393Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835539</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383553</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:09.220Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835768</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383576</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:09.203Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835782</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383578</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:08.736Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835515</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383551</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:08.633Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835584</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383558</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:08.590Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835560</udiDi>
    <basicUdiDi>038290YTGMENXNP8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383556</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:08.236Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835775</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383577</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:08.169Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835805</udiDi>
    <basicUdiDi>038290XFLLRZJML8</basicUdiDi>
    <tradeName>Nexiva Maxzero</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383580</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T19:48:07.527Z</lastUpdated>
  </row>
</eudamedExport>